2seventy bio, Inc. (TSVT)
USD 2.97
(-7.48%)
USD 2.97
(-7.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -166.85 Million | -237.13 Million | -207.03 Million | -67.79 Million | -207.95 Million | -146.21 Million |
| Net Income | -217.57 Million | -254.15 Million | -292.21 Million | -120.11 Million | -320.59 Million | -199.74 Million |
| Depreciation & Amortization | 10.28 Million | 11.53 Million | 16.35 Million | 13.18 Million | 12.58 Million | 13.34 Million |
| Deferred income taxes | 423 Thousand | - | - | - | - | - |
| Stock-based compensation | 32.15 Million | 41.04 Million | 54.62 Million | 60.99 Million | 62.04 Million | 40.8 Million |
| Change in working capital | 2.6 Million | -35.87 Million | 13.33 Million | -15.46 Million | 35.14 Million | -3.81 Million |
| Other non-cash items | 5.24 Million | 317 Thousand | 869 Thousand | -6.39 Million | 2.85 Million | 3.2 Million |
| Investing Cash Flow | 43.86 Million | 11.69 Million | 15.41 Million | -22.26 Million | -59.76 Million | -50.82 Million |
| Investments in PPE | -13.86 Million | -22.84 Million | -19.57 Million | -22.26 Million | -59.76 Million | -50.82 Million |
| Acquisitions | -18 Million | -34.53 Million | - | - | - | - |
| Investment purchases | -265.17 Million | -145.9 Million | - | - | - | - |
| Sales/Maturities of investments | 322.89 Million | 180.44 Million | 34.98 Million | - | - | - |
| Other Investing Activities | 18 Million | 34.53 Million | -32.99 Million | - | - | - |
| Financing Cash Flow | 127.39 Million | 166.22 Million | 354.88 Million | 90.05 Million | 267.72 Million | 197.04 Million |
| Debt repayment | - | - | - | - | - | -1.01 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 127.39 Million | 165.53 Million | 6.54 Million | - | - | - |
| Other Financing Activities | 127.39 Million | 696 Thousand | 348.34 Million | 90.05 Million | 267.72 Million | 198.05 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -423 Thousand | 327 Thousand | -6000.00 | -13.24 Million | 14.61 Million | 2.23 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.02 Million | -36.19 Million | 13.33 Million | -2.22 Million | 20.53 Million | -6.04 Million |
| Cash at beginning of period | 71.03 Million | 163.26 Million | - | - | - | - |
| Cash at end of period | 74.95 Million | 104.05 Million | 163.26 Million | - | - | - |
| Capital Expenditure | -13.86 Million | -22.84 Million | -19.57 Million | -22.26 Million | -59.76 Million | -50.82 Million |
| Effect of forex changes on cash | -467 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | 3.92 Million | -59.2 Million | 163.26 Million | - | - | - |
| Free Cash Flow | -180.72 Million | -259.97 Million | -226.6 Million | -90.05 Million | -267.72 Million | -197.04 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 24.87 Million | -52.67 Million | -56.82 Million | -217.57 Million | -71.63 Million | -42.08 Million |
| Depreciation & Amortization | 1.67 Million | 2.1 Million | 3.03 Million | 10.28 Million | 2.76 Million | 2.23 Million |
| Deferred income taxes | - | - | -10.42 Million | 423 Thousand | 12.05 Million | - |
| Stock-based compensation | 2.38 Million | 4.68 Million | 4.95 Million | 32.15 Million | 9.8 Million | 7.74 Million |
| Change in working capital | -2.35 Million | 2.01 Million | -13.06 Million | 2.6 Million | 27.75 Million | 772 Thousand |
| Other non-cash items | -38.24 Million | 7.63 Million | 8.73 Million | 5.24 Million | -2.24 Million | -1.32 Million |
| Investing Cash Flow | 78.43 Million | 21.83 Million | 47.89 Million | 43.86 Million | 16.05 Million | -64.88 Million |
| Investments in PPE | -61 Thousand | -612 Thousand | -1.07 Million | -13.86 Million | -2.74 Million | -3.97 Million |
| Acquisitions | 43 Million | 176 Thousand | 447 Thousand | -18 Million | - | - |
| Investment purchases | -7.01 Million | -22.73 Million | -21.03 Million | -265.17 Million | -81.62 Million | -119.43 Million |
| Sales/Maturities of investments | 42.51 Million | 45 Million | 70 Million | 322.89 Million | 100.42 Million | 58.5 Million |
| Other Investing Activities | 42.84 Million | -1.16 Million | -447 Thousand | 18 Million | 2000.00 | 21 Thousand |
| Financing Cash Flow | -24 Thousand | 386 Thousand | 253 Thousand | 127.39 Million | -75 Thousand | 128 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 75 Thousand | - | -75 Thousand | - |
| Common Stock Issuance | -24 Thousand | 386 Thousand | 253 Thousand | 127.39 Million | -75 Thousand | 128 Thousand |
| Other Financing Activities | -24 Thousand | 386 Thousand | 253 Thousand | 127.39 Million | - | 128 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -5.74 Million | 3.25 Million | 592 Thousand | -423 Thousand | -519 Thousand | -7.56 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.38 Million | -1.24 Million | -13.65 Million | 3.02 Million | 28.27 Million | 8.34 Million |
| Cash at beginning of period | 56.79 Million | 74.95 Million | 90.22 Million | 71.03 Million | 97.66 Million | 195.08 Million |
| Cash at end of period | 111.86 Million | 56.79 Million | 74.95 Million | 74.95 Million | 92.13 Million | 97.66 Million |
| Capital Expenditure | -61 Thousand | -612 Thousand | -1.07 Million | -13.86 Million | -2.74 Million | -3.97 Million |
| Effect of forex changes on cash | - | - | 184 Thousand | -467 Thousand | - | - |
| Net cash flow / Change in cash | 55.07 Million | -18.16 Million | -15.26 Million | 3.92 Million | -5.53 Million | -97.41 Million |
| Free Cash Flow | -23.2 Million | -42.48 Million | -64.66 Million | -180.72 Million | -24.25 Million | -36.63 Million |
UTLINDS
PVE
ELZ
3222
AIA
BIG